Cargando…
Evaluation of immunologic parameters in canine glioma patients treated with an oncolytic herpes virus
AIM: To molecularly characterize the tumor microenvironment and evaluate immunologic parameters in canine glioma patients before and after treatment with oncolytic human IL-12-expressing herpes simplex virus (M032) and in treatment naïve canine gliomas. METHODS: We assessed pet dogs with sporadicall...
Autores principales: | Chambers, M. R., Foote, J. B., Bentley, R. T., Botta, D., Crossman, D. K., Della Manna, D. L., Estevez-Ordonez, D., Koehler, J. W., Langford, C. P., Miller, M. A., Markert, J. M., Olivier, A. K., Omar, N. B., Platt, S. R., Rissi, D. R., Shores, A., Sorjonen, D. C., Yang, E. S., Yanke, A. B., Gillespie, G. Y. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8955901/ https://www.ncbi.nlm.nih.gov/pubmed/35342877 http://dx.doi.org/10.20517/jtgg.2021.31 |
Ejemplares similares
-
The One Health Consortium: Design of a Phase I Clinical Trial to Evaluate M032, a Genetically Engineered HSV-1 Expressing IL-12, in Combination With a Checkpoint Inhibitor in Canine Patients With Sporadic High Grade Gliomas
por: Chambers, M. R., et al.
Publicado: (2020) -
Combination strategies enhance oncolytic virotherapy
por: Friedman, Gregory K., et al.
Publicado: (2017) -
Targeting Pediatric Cancer Stem Cells with Oncolytic Virotherapy
por: Friedman, Gregory K., et al.
Publicado: (2012) -
Pre-clinical Assessment of C134, a Chimeric Oncolytic Herpes Simplex Virus, in Mice and Non-human Primates
por: Cassady, Kevin A., et al.
Publicado: (2017) -
Adjuvant oncolytic virotherapy for personalized anti-cancer vaccination
por: Roy, D. G., et al.
Publicado: (2021)